Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Stay focused on the facts

<< Previous

Bullboard Posts

Next >>

Comment by Biobobon Mar 23, 2022 10:47am

64 Views

Post# 34537605

RE:RE:RE:RE:RE:RE:Stay focused on the facts

If we can just fill the rogue seller and get back to business. I would expect Soleus to grab the opportunity if they are still beleivers in Th1902. It is pure stupidity sometimes. I client of mine switched brokers in 2017 and called me when Th was 10$+ in dismay... the other guy sold at 2$ his 320 000 shares... hope it's the case for this imbecile next year.

<< Previous

Bullboard Posts

Next >>

Boeing workers end strike, return to work